Inhibition of class I HDAC activity in prostate tumor cells [20,68]Acetylation of H3 histone in breast tumor cells [101]Inhibition of the activity of 5-cytosine DNMTs and silencing of NRF2 in skin epidermal cells [67]Induction of the expression of miR-16 and miR215-5p in glioma and colon cancer [7]. The gene discussed is NFE2L2; the disease is breast neoplasm.